Canoo Inc. Announces Chapter 7 Bankruptcy Filing
January 17, 2025 20:15 ET
|
Canoo, Inc.
JUSTIN, Texas, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Canoo Inc. (Nasdaq: GOEV), (the "Company"), a high-tech advanced mobility and energy company, today announced that it has filed a voluntary petition...
SIMPPLE Ltd. Receives Nasdaq Notifications Regarding Minimum Stockholders’ Equity Deficiency and Annual Meeting Deficiency
January 17, 2025 19:00 ET
|
SIMPPLE Ltd.
Singapore, Jan. 17, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), an advanced technology solution provider in the emerging property-technology (“PropTech”)...
Uniti Group Inc. Announces Pricing of $589 Million Fiber Securitization Notes Offering
January 17, 2025 18:15 ET
|
Uniti Group Inc.
LITTLE ROCK, Ark., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Uniti Group Inc. (the “Company,” “Uniti,” or “we”) (Nasdaq: UNIT) today announced that Uniti Fiber ABS Issuer LLC and Uniti Fiber TRS Issuer LLC,...
Lifecore Biomedical Announces Special Stockholder Meeting
January 17, 2025 17:24 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Mawson Infrastructure Group Inc. Appoints William C. Regan as Chief Financial Officer
January 17, 2025 17:15 ET
|
Mawson Infrastructure Group Inc.
MIDLAND, Pa., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson” or “the Company”), a publicly-traded technology company focused on digital infrastructure...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
January 17, 2025 17:00 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and...
XORTX Announces Change of Auditor
January 17, 2025 17:00 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, Jan. 17, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company...
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 17, 2025 16:30 ET
|
Xilio Therapeutics, Inc.
WALTHAM, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies...
Dime Announces Continued Partnership for the Dime McCarren 5K in 2025
January 17, 2025 16:30 ET
|
Dime Community Bancshares, Inc.
HAUPPAUGE, N.Y., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (Nasdaq: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”) today announced...
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 17, 2025 16:30 ET
|
Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...